Strategy. Execution. Transactions.

A Boutique Consultancy and Business Broker for the Life Sciences Industry.

Guiding Biopharma Through Strategy and Execution Since 2017

Founded by entrepreneurs and corporate strategists, Exycute is a Boston-based advisory firm built to support leaders across biotech, pharma, and life sciences investment. We specialize in strategic advisory and transactional execution—helping clients navigate inflection points with clarity and discipline.

Whether you’re building a NewCo, evaluating an acquisition, or preparing for launch, we work across the full arc of company-building and dealmaking. We engage when it’s complex. When the path isn’t obvious. When it’s time to execute.

Areas of Practice

Corporate Advisory

We help clients define their scientific and business models, shape NewCos, prioritize R&D portfolios, and build the organizational systems needed to execute. From concept to scale, we support the full arc of company development.

Transactions and M&A

We advise on buy-side and sell-side deals, asset bundling, spinouts, and carve-outs. Our work spans diligence, valuation modeling, integration planning, and negotiation strategy—always anchored in long-term value creation.

Market intelligence and growth planning

We analyze therapeutic landscapes, clinical pipelines, regulatory shifts, and competitive positioning to support investment decisions, product planning, and early commercial infrastructure. Insight drives action.

“The biology is easy. It’s the decisions that are hard.”

– Vicki Sato, Former President, Vertex Pharmaceuticals; Professor, Harvard Business School

Get in Touch

We work selectively and confidentially. If you’re building, acquiring, or navigating a strategic decision in life sciences, we’re open to a conversation.

Let us know how we can help.